Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 1—January 2011
Research

Concurrent Conditions and Human Listeriosis, England, 1999–2009

Piers MookComments to Author , Sarah J. O’Brien, and Iain A. Gillespie
Author affiliations: Author affiliations: Health Protection Agency, London, UK (P. Mook, I.A. Gillespie); University of Manchester, Manchester, UK (S.J. O’Brien, I.A. Gillespie)

Main Article

Table A1

ICD-10 diagnosis codes for concurrent conditions among patients with non–pregnancy-associated listeriosis, showing rate of identification/FCE for each condition and comparison of all patients with patients >60 years of age, England, 1999–2009*

Chapter and subgroup (code) All patients
Patient age >60 y
No. cases FCE No. cases/million FCE (95% CI) No. cases FCE No. cases/million FCE (95% CI)
Certain infectious and parasitic diseases (A00–B99)
21
175,8220
11.9 (7.39–18.3)

10
467,930
21.4 (10.2–39.3)
Neoplasms (C00–D48) 456 1,449,3620 31.5 (28.6–34.5) 368 860,9476 42.7 (38.5–47.3)
Digestive organs (C15–C26) 72 2,665,050 27.0 (21.1–34.0) 64 1,967,238 32.5 (25.1–41.5)
Respiratory and intrathoracic organs (C30–C39) 41 965,504 42.5 (30.5–57.6) 39 727,468 53.6 (38.1–73.3)
Breast (C50) 36 1,382,014 26.0 (18.2–36.1) 22 515,774 42.7 (26.7–64.6)
Female genital organs (C51–C58) 10 587,403 17.0 (8.2–31.3) 7 345,555 NC
Male genital organs (C60–C63) 13 490,644 26.5 (14.1–45.3) 13 389,305 33.4 (17.8–57.1)
Eye, brain, and other parts of central nervous system (C69–C72) 13 196,199 66.3 (35.3–113.3) 11 58,414 188.3 (94–336.9)
Thyroid and other endocrine glands (C73–C80, C97) 47 1,957,683 24 (17.6–31.9) 37 1,053,496 35.1 (24.7–48.4)
Lymphoid, hematopoietic, and related tissue (C81–C96) 187 1,359,740 137.5 (118.5–158.7) 145 753,816 192.4 (162.3–226.3)
In situ and benign neoplasms and others of uncertainty (D00–D48)
18
2,880,269
6.3 (3.7–9.9)

16
1,286,473
12.4 (7.11–20.2)
Diseases of the blood and blood-forming organs and certain
disorders involving the immune mechanism (D50–D89) 25 2,062,183 12.1 (7.85–17.9) 12 1,079,281 11.1 (5.75–19.4)
Anemias (D50–D64) 13 1,478,008 8.8 (4.68–15) 7 871,585 NC
Diseases of blood and blood-forming organs (D65–D89)
12
584,175
20.5 (10.6–35.9)

5
207,696
NC
Endocrine, nutritional and metabolic diseases (E00–E90) 83 1,831,366 45.3 (36.1–56.2) 69 804,961 85.7 (66.7–108.5)
Diabetes mellitus (E10–E14)
71
721,573
98.4 (76.8–124.1)

57
326,473
174.6 (132.2–226.2)
Mental and behavior disorders (F00–F99) 60 2,176,420 27.6 (21.0–35.5) 25 646,228 38.7 (25.0–57.1)
Due to psychoactive substance (F10–F19)
54
502,363
107.5 (80.8–140.3)

20
56,062
356.7 (217.9–550.9)
Diseases of the nervous system (G00–G99) 16 2,732,564 5.86 (3.35–9.51) 15 1,141,845 13.1 (7.35–21.7)
Diseases of the eye and adnexa (H00–H59) 1 4,392,414 NC 0 3,449,215 NC
Diseases of the ear and mastoid process (H60–H95)
0
858,208
NC

0
125,850
NC
Diseases of the circulatory system (I00–I99) 143 11,770,385 12.1 (10.2–14.3) 135 8,514,080 15.9 (13.3–18.8)
Hypertensive diseases (I10–I15) 22 306,847 71.7 (44.9–108.5) 18 193,565 93 (55.1–147)
Ischemic heart diseases (I20–I25) 29 4,079,434 7.11 (4.76–10.2) 27 2,992,521 9.02 (5.95–13.1)
Other forms of heart disease (I30–I52) 62 2,928,710 21.2 (16.2–27.1) 61 2,366,977 25.8 (19.7–33.1)
Cerebrovascular diseases (I60–I69) 10 1,656,546 6.04 (2.89–11.1) 10 1,410,024 7.09 (3.4–13)
Diseases of arteries, arterioles, and capillaries (I70–I79)
14
747,731
18.7 (10.2–31.4)

13
590,657
22.0 (11.7–37.6)
Diseases of the respiratory system (J00–J99) 66 8,441,191 7.82 (6.1–10.0) 61 4,237,898 14.4 (11.0–18.5)
Chronic lower respiratory diseases (J40–J47) 41 2,510,375 16.3 (11.7–22.2) 40 1,627,030 24.6 (17.6–33.5)
Other diseases of the respiratory system (J80–J99)
11
702,393
15.7 (7.82–28)

10
458,712
21.8 (10.5–40.1)
Diseases of the digestive system (K00–K93) 163 14607104 11.2 (9.5–13.0) 96 6288251 15.3 (12.4–18.6)
Noninfective enteritis and colitis (K50–K52) 60 1,582,958 37.9 (28.9–48.8) 33 547,430 60.3 (41.5–84.7)
Other diseases of intestines (K55–K63) 14 2,985,107 4.69 (2.56–7.87) 13 1,623,725 8.01 (4.26–13.7)
Diseases of liver (K70–K77)
72
373,347
192.9 (150.9–242.9)

38
124,000
306.5 (216.9–420.6)
Diseases of the skin and subcutaneous tissue (L00–L99)
6
2,913,757
NC

6
1,066,962
NC
Diseases of the musculoskeletal system and connective tissue
(M00–M99) 97 8,106,829 12.0 (9.7–14.6) 77 3,758,159 20.5 (16.2–25.6)
Arthropathies (M00–M25) 60 3,925,790 15.3 (11.7–19.7) 52 2,016,907 25.8 (19.3–33.8)
Systemic connective tissue disorders (M30–M36)
28
171,687
163.1 (108.4–235.7)

19
67,700
280.6 (169.0–438.2)
Diseases of the genitourinary system (N00–N99) 94 8,529,328 11.0 (8.9–13.5) 73 3,392,932 21.5 (16.9–27.1)
Renal failure (N17–N19)
90
869,322
103.5 (83.3–127.3)

69
577,799
119.4 (92.9–151.1)
Pregnancy, childbirth, and puerperium (O00–O99) 0 1,2614,774 NC 0 45,099 NC
Certain conditions originating in the perinatal period (P00–P96) 0 1,928,377 NC 0 433 NC
Congenital malformations, deformations, and chromosomal abnormalities (Q00–Q99) 1 1,069,074 NC 1 38,859 NC
Symptoms, signs, and abnormal clinical and laboratory findings not elsewhere classified (R00–R99) 2 16,380,896 NC 2 7,580,878 NC
Injury, poisoning, and certain other consequences of external causes (S00–T98) 4 8,723,795 NC 1 3,213,017 NC
External causes of morbidity and mortality (V01–Y98) 0 0
Factors influencing health status and contact with health services (Z00–Z99) 1 10,621,404 NC 1 2,070,369 NC
Codes for special purposes (U00–U99)
0



0


Total 1,239 13,601,1909 9.1 (8.6–9.6) 951 56,531,723 16.8 (15.8–17.9)

*ICD, International Classification of Diseases, 10th Revision; FCE, finished consultant episodes; CI, confidence interval; NC, not calculated (for conditions with <10 cases); –, data not available.

*ICD, International Classification of Diseases, 10th Revision; FCE, finished consultant episodes; CI, confidence interval; NC, not calculated (for conditions with <10 cases); –, data not available.

Main Article

Page created: July 08, 2011
Page updated: July 08, 2011
Page reviewed: July 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external